Cancer Treatments
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
225
NCT07105488
A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis
Phase: Phase 2
Role: Lead Sponsor
Start: Jul 15, 2025
Completion: Mar 31, 2027
Loading map...